Physicians recommend that patients with chronic obstructive pulmonary disease (COPD) quit smoking and use steroids, ...
1don MSN
Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...
News Medical on MSN1d
Addressing COPD and metabolic syndrome requires comprehensive research effortsAdditional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...
Fexlamose is being developed as a chronic treatment for COPD and asthma in conjunction with standard therapies, to improve ...
healthday on MSN38m
Childhood Smoking Ups COPD RiskYoung teens might think smoking makes them look cool, but it’s likely to take their breath away in adulthood, a new st ...
Childhood smoking before age 15 increases a person's risk of developing chronic obstructive pulmonary disease (COPD), ...
News Medical on MSN3d
Smoking before age 15 linked to higher COPD riskChildhood smoking before age 15 increases a person's risk of developing chronic obstructive pulmonary disease (COPD), ...
TRN-157 is under clinical development by Theron Pharmaceuticals and currently in Phase I for Chronic Obstructive Pulmonary Disease (COPD).
AZD-6793 is under clinical development by AstraZeneca and currently in Phase I for Chronic Obstructive Pulmonary Disease (COPD).
For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback